DuPont Co. (2000).

Does not contain TSCA CM DuPont-4670 SUMMARY ?

AR226-2808 TRADE SECRET Study Title H-24750: Biopersistence Screening 10-Dose Oral Gavage Study in Rats Laboratory Project ED: DuPont-11561 AUTHOR: CarolFinlay,B.A.

.-.' 06/21/2001 02:16 PM To: cc: Subject: Catherine A Barton/AE/DuPont@DuPont Fayetlaville Results Cathie.

AR226-3064 DuPont HIiR 904-96 ttxaggT.T.

AR226-2011 ^\\\ Oo^ //TO WASHINGTONWORKS ILNFLUENCE C-8 ENVIRONMENTA EID924245 WASHINGTON WORKS C-8 ENVIRONMENTAL INFLUENCE EID924246 WASHINGTON WORKS C-8 ENVIRONMENTAL INFLUENCE EID924247 AIR PROGRAMS Liquid, C-8 Facilities Fine Powder Dryer Recovery Project Fence Line Monitoring 8/89, Complete 1Q90, Start-up , Transition Inconclusive EID924248 VASHINQTON WORKS C-8 ENVIRONMENTAL INFLUENCE ETD924249 WATER PROGRAMS Surface Possible C-8 Recovery From FEP Effluent In Progress 1992 Groundwater Purchase of Lubeck Water Company Closing 4/11/90 Turnover to DuPont 10/91-4/92 EID924250 WASHINGTON WORKS C-8 ENVIRONMENTAL INFLUENCE EID924251 LAND PROGRAMS DuPont Letart Landfill Eliminated Empty Raw Material Drum Disposal West Virginia Regs.

Any expenses incurred as a result of accurately supplying the information requested above shall be covered by DuPont.

AR226-3064 DuPont HLR 904-96 BASKS&L LABORATORY VOS.

TprhoeviidnefdorvmoaltuinotnarpirloyvtiodeEdPiAn tinheeJsapnounasrey f25o,42r0e0q1uesatndfrJoumneMr2.3,C2h0ar0l0essubAmuiesrsfioornsexwpaossure and use information from DuPont percaining to the substance in issue.

Director ~ Regulatory Affairs and Occupational Health : AMK:clp (302) 366-5260 Enclosure (1): APFO (Linear/Branched), APFO (Linear), and APFO(Branched): 14-Day Oral Gavage Study in Male Rats and Mice; DuPont-14162 ar------

to the raqitert for participation by Ohio EPA on the OIST, Dupont is prqwed to iadertake voluntarily a well survey and sampling of private grouniwatef wells in Ac ares of the Littie HocldBg WatCT As$oiartion well field following Afl pintocol tfiat lias been establish uncler the MMCO.

a t- Debbie J Mulrooney | .T 05/21/2001 02:16 PM I To: Catherine A Barton/AE/DuPont@DuPont cc: Subject: Fayetteville Results Cathie, Here is a summary of vapor phase modeling results for the four cases we've looked at so far.

AR226-3063 DuPont HLR 903-96 HASKKLXi XABOXXTOX?

inter-office communicatio to: from: subject: date: Chris Jones Bob Hodanbosi, papc October 29, 2002 1erver DuPont, West Virginia cg December 3, 2002 We are Preparing several a-letter a letter for your signature in b(yStaeitrtienmuisss&ioHnosllsoiswtreirttLeLnb P)yAonttboerhnaelfy response to oRfobOehritoaciBtiilzoetnts (Taft, impacteq .

AR226-3004 DuPont HLR2S7-S4 HASKELL LABORATORY FOR TOXICOLOGY AND INDUSTRIAL MEDICINE STATIC.